Development of a therapeutic anti-marinobufagenin antibody
Development of a therapeutic anti-marinobufagenin antibody
批准号:
8552492
负责人:
Alexei Bagrov
金额:
$61.48万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
Active ImmunizationAffectAntibodiesBlood PressureBlood VesselsCardiacCardiac GlycosidesCardiomyopathiesChronic Kidney FailureCollagenControl AnimalDevelopmentDisodium Salt NitroprussideEndothelin-1Excretory functionExhibitsFibrosisHeart HypertrophyHypertensionMonoclonal AntibodiesNa(+)-K(+)-Exchanging ATPaseNon-Insulin-Dependent Diabetes MellitusNuclearOxidative StressPlasmaPre-EclampsiaProteinsRattusStreptozocinTestingTherapeuticTherapeutic EffectThoracic aortaVascular Smooth MuscleWeightWistar Ratsconstrictionin vivointraperitonealmalemarinobufageninresponsesalt sensitivetranscription factorurinary
中文摘要
在PNx大鼠中,我们研究了3E9抗mbg单克隆抗体(mAb)对血压和心肌肥厚及纤维化的影响。在PNx大鼠中,血浆MBG水平升高4倍与高血压、心脏羰基化蛋白水平升高、心脏肥厚、心脏核转录因子(胶原合成的负调节因子Fli-1)表达减少以及胶原-1水平升高有关。PNx大鼠单次腹腔注射3E9 mAb,连续7天降低血压59 mmHg,并显著降低心脏重量和心脏氧化应激水平。这些作用与Fli-1表达的增加和心脏纤维化的减少有关。因此,在慢性肾衰竭中,MBG通过抑制Fli-1导致高血压并诱导心脏纤维化,这是一个潜在的治疗靶点。
英文摘要
In PNx rats, we studied effects of 3E9 anti-MBG monoclonal antibody (mAb) on BP and cardiac hypertrophy and fibrosis. In PNx rats, a four-fold elevation in plasma MBG levels was associated with hypertension, increased cardiac levels of carbonylated protein, cardiac hypertrophy, a reduction in cardiac expression of a nuclear transcription factor which is a negative regulator of collagen synthesis, Fli-1, and an increase in the levels of collagen-1. A single intraperitoneal administration of 3E9 mAb to PNx rats reduced BP by 59 mmHg for 7 days and significantly reduced cardiac weight and cardiac levels of oxidative stress. These effects were associated with an increase in the expression of Fli-1, and a reduction in cardiac fibrosis. Thus, in chronic renal failure MBG contributes to hypertension and induces cardiac fibrosis via suppression of Fli-1, representing a potential target for therapy.
Because previously in uremic rats active immunization against MBG reduced cardiac fibrosis but minimally affected BP, we hypothesized that MBG induces vascular fibrosis via BP-independent mechanism. We determined BP, plasma and urinary MBG, aortic collagen-1, and vascular function in NaCl-loaded male Wistar rats with streptozotocin-induced type 2 diabetes mellitus (DM-NaCl) and in control animals. Isolated rings of thoracic aortae were tested for their responsiveness to sodium nitroprusside (SNP) following endothelin-1-induced constriction. DM-NaCl rats exhibited a 3.5-fold increase in MBG excretion and 2.5-fold increase in levels of collagen-1 in thoracic aortae without changes of BP. As compared to control, aortic rings from DM-NaCl rats exhibited impaired response to the relaxant effect of SNP. In vivo administration of 3E9 mAb to DM-NaCl rats did not affect BP, but reduced aortic levels of collagen-1, and restored sensitivity of aortic rings to SNP.
Thus, MBG is capable to increase vascular stiffness without affecting BP.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Aging and interaction of natriuretic factors on renal and vascular sodium pump
-
批准号:8736638
-
项目类别:
-
资助金额:$41.83万
-
财政年份:--
-
负责人:Alexei Bagrov
-
依托单位:
Sodium Pump Inhibitors In Blood Pressure Regulation
-
批准号:8736576
-
项目类别:
-
资助金额:$43.8万
-
财政年份:--
-
负责人:Alexei Bagrov
-
依托单位:
Marinobufagenin as a therapeutic target
-
批准号:9147364
-
项目类别:
-
资助金额:$54.3万
-
财政年份:--
-
负责人:Alexei Bagrov
-
依托单位:
Development of a therapeutic anti-marinobufagenin antibody
-
批准号:8335946
-
项目类别:
-
资助金额:$37.73万
-
财政年份:--
-
负责人:Alexei Bagrov
-
依托单位:
Aging and interaction of natriuretic factors on renal and vascular sodium pump
-
批准号:8335945
-
项目类别:
-
资助金额:$21.77万
-
财政年份:--
-
负责人:Alexei Bagrov
-
依托单位:
Development of a therapeutic anti-marinobufagenin antibody
-
批准号:8148335
-
项目类别:
-
资助金额:$28.29万
-
财政年份:--
-
负责人:Alexei Bagrov
-
依托单位:
Aging and interaction of natriuretic factors on renal and vascular sodium pump
-
批准号:9147363
-
项目类别:
-
资助金额:$63.45万
-
财政年份:--
-
负责人:Alexei Bagrov
-
依托单位:
Development of a therapeutic anti-marinobufagenin antibody
-
批准号:7964071
-
项目类别:
-
资助金额:$44.05万
-
财政年份:--
-
负责人:Alexei Bagrov
-
依托单位:
Sodium Pump Inhibitors In Blood Pressure Regulation
-
批准号:8335876
-
项目类别:
-
资助金额:$26.12万
-
财政年份:--
-
负责人:Alexei Bagrov
-
依托单位:
Development of a therapeutic anti-marinobufagenin antibody
-
批准号:8931610
-
项目类别:
-
资助金额:$56.62万
-
财政年份:--
-
负责人:Alexei Bagrov
-
依托单位:
Sodium Pump Inhibitors In Blood Pressure Regulation
-
批准号:7963990
-
项目类别:
-
资助金额:$35.01万
-
财政年份:--
-
负责人:Alexei Bagrov
-
依托单位:
Aging and interaction of natriuretic factors on renal and vascular sodium pump
-
批准号:8931609
-
项目类别:
-
资助金额:$56.62万
-
财政年份:--
-
负责人:Alexei Bagrov
-
依托单位:
Sodium Pump Inhibitors In Blood Pressure Regulation
-
批准号:8148271
-
项目类别:
-
资助金额:$19.59万
-
财政年份:--
-
负责人:Alexei Bagrov
-
依托单位:
Development of a therapeutic anti-marinobufagenin antibody
-
批准号:7732338
-
项目类别:
-
资助金额:$46.67万
-
财政年份:--
-
负责人:Alexei Bagrov
-
依托单位:
Aging and interaction of natriuretic factors on renal and vascular sodium pump
-
批准号:7732337
-
项目类别:
-
资助金额:$38.89万
-
财政年份:--
-
负责人:Alexei Bagrov
-
依托单位:
Sodium pump inhibitors in blood pressure regulation and in profibrotic signaling in salt sensitive hypertension and aging
-
批准号:8931554
-
项目类别:
-
资助金额:$56.88万
-
财政年份:--
-
负责人:Alexei Bagrov
-
依托单位:
Aging and interaction of natriuretic factors on renal and vascular sodium pump
-
批准号:7964070
-
项目类别:
-
资助金额:$32.75万
-
财政年份:--
-
负责人:Alexei Bagrov
-
依托单位:
Aging and interaction of natriuretic factors on renal and vascular sodium pump
-
批准号:8552491
-
项目类别:
-
资助金额:$36.56万
-
财政年份:--
-
负责人:Alexei Bagrov
-
依托单位:
Aging and interaction of natriuretic factors on renal and vascular sodium pump
-
批准号:8148334
-
项目类别:
-
资助金额:$16.32万
-
财政年份:--
-
负责人:Alexei Bagrov
-
依托单位:
Sodium Pump Inhibitors In Blood Pressure Regulation
-
批准号:8552423
-
项目类别:
-
资助金额:$58.16万
-
财政年份:--
-
负责人:Alexei Bagrov
-
依托单位:
海外基金